• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Today's Weak On High Volume Stock: PSivida (PSDV)

  • By TheStreet Wire
  • Dec 29, 2015 10:17 AM EST
3 Leisure Stocks Pushing Industry Growth
MARKETS

Trade-Ideas: PSivida (PSDV) Is Today's Strong On High Relative Volume Stock

  • By TheStreet Wire
  • Dec 28, 2015 10:14 AM EST
Will Amazon.com (AMZN) Stock be Affected by New E-Book Author Royalty Plan?
MARKETS

Psivida (PSDV) Upgraded From Sell to Hold

  • By TheStreet Quant Ratings
  • Nov 21, 2014 9:22 AM EST
Dick's Sporting Goods (DKS) Stock Declines Pre-Market on Weak First Quarter SSS
MARKETS

Why pSivida (PSDV) Stock Is Soaring in After-Hours Trading Today

  • By Andrew Meola
  • Sep 26, 2014 5:15 PM EDT
5 Heavily Shorted Stocks Set to Soar on Bullish Earnings
INVESTING

3 Stocks Under $10 Moving Higher

  • By Roberto Pedone
  • Jan 29, 2014 7:00 AM EST
Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed
STOCKS

Alimera, pSivida Eye Drug Rejected by FDA

  • By Adam Feuerstein
  • Oct 18, 2013 7:28 AM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING

6 Stocks Moving on Unusual Volume

  • By Roberto Pedone
  • Sep 13, 2013 9:31 AM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Alimera, pSivida Eye Drug Warrants FDA Approval On Third Try

  • By David Sobek
  • Aug 28, 2013 9:30 AM EDT
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Stock Mailbag: Sarepta, Inovio, FDA Calendar, Ken Luskin's Angry Vical Voice Mail

  • By Adam Feuerstein
  • Aug 9, 2013 6:00 AM EDT
4 Under-$10 Biotech Stocks in Breakout Territory
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Jun 20, 2013 1:53 PM EDT
Hedge Funds Love These 5 Consumer Stocks -- but Should You?
INVESTING

4 Stocks Under $10 Making Big Moves

  • By Roberto Pedone
  • May 29, 2013 2:21 PM EDT
Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

2013 FDA Drug Approval Calendar

  • By Adam Feuerstein
  • May 21, 2013 7:00 AM EDT
5 Bargain Bin Stocks to Buy in March
INVESTING

5 Stocks Under $10 Set to Surge

  • By Roberto Pedone
  • May 2, 2013 2:08 PM EDT
Consider Buy Rated Stocks Under Five Bucks as Stocking Stuffers
MARKETS

4 Stocks Under $10 Making Big Moves

  • By Roberto Pedone
  • Jul 24, 2012 2:17 PM EDT
5 Stocks Poised for Breakouts
MARKETS

5 Stocks Poised for Breakouts

  • By Roberto Pedone
  • Jun 29, 2012 12:45 PM EDT
Inflating Market Bubble Not Quite Ready to Pop
MARKETS

5 Stocks Setting Up to Break Out

  • By Roberto Pedone
  • Apr 25, 2012 11:32 AM EDT
5 Bargain Bin Stocks to Buy in March
INVESTING

8 Stocks Under $10 Moving Higher

  • By Roberto Pedone
  • Mar 27, 2012 2:11 PM EDT
Hedge Funds Love These 5 Consumer Stocks -- but Should You?
INVESTING

5 Stocks Under $5 Making Big Moves

  • By Roberto Pedone
  • Feb 24, 2012 2:16 PM EST
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Calendar: Key Dates for November

  • By Adam Feuerstein
  • Nov 1, 2011 10:04 AM EDT
Spectrum Pharma Implodes On Colossal Fusilev Sales Warning
STOCKS

Biotech Calendar: 2011 FDA Drug Approvals

  • By Adam Feuerstein
  • May 25, 2011 7:00 AM EDT
Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS

Biotech Calendar: 2011 FDA Drug Approvals

  • By Adam Feuerstein
  • Feb 22, 2011 7:36 AM EST
Biotech Sector Weekly Rewind
STOCKS

Biotech Calendar: FDA Drug Approvals in 2011

  • By Adam Feuerstein
  • Dec 13, 2010 7:19 AM EST
INVESTING

pSivida - Upgrades & Downgrades

  • By Kevin Baker
  • Sep 24, 2010 1:51 PM EDT
Grom Social Offers a Safe Alternative to Facebook for Young People
STOCKS

Chromcraft, pSivida: Midday Volume Plays

  • By Robert Holmes
  • Nov 18, 2009 1:34 PM EST
Grom Social Offers a Safe Alternative to Facebook for Young People
INVESTING

Monday's Health Winners & Losers

  • By Elizabeth Trotta
  • Jul 2, 2007 3:37 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.